Pertussis Booster Vaccination in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy
暂无分享,去创建一个
W. Borkowsky | K. Edwards | M. Levin | S. Pelton | M. Abzug | S. Nachman | H. Rosenblatt | T. Fenton | Jody Peters | Lin-Ye Song | K. Edwards
[1] W. Borkowsky,et al. Immunogenicity, Safety, and Predictors of Response After a Pneumococcal Conjugate and Pneumococcal Polysaccharide Vaccine Series in Human Immunodeficiency Virus-Infected Children Receiving Highly Active Antiretroviral Therapy , 2006, The Pediatric infectious disease journal.
[2] T. Kuijpers,et al. Persistent Humoral Immune Defect in Highly Active Antiretroviral Therapy–Treated Children With HIV-1 Infection: Loss of Specific Antibodies Against Attenuated Vaccine Strains and Natural Viral Infection , 2006, Pediatrics.
[3] J. Hedrick,et al. Acellular Pertussis Vaccine Booster Combined With Diphtheria and Tetanus Toxoids for Adolescents , 2006, Pediatrics.
[4] Philimon N. Gona,et al. Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy. , 2006, The Journal of infectious diseases.
[5] P. Krogstad,et al. Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection. , 2005, The Journal of allergy and clinical immunology.
[6] K. Edwards,et al. Establishment of Diagnostic Cutoff Points for Levels of Serum Antibodies to Pertussis Toxin, Filamentous Hemagglutinin, and Fimbriae in Adolescents and Adults in the United States , 2004, Clinical Diagnostic Laboratory Immunology.
[7] D. Greenberg,et al. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. , 2004, The Journal of infectious diseases.
[8] B. LaFleur,et al. Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy. , 2004, The Journal of infectious diseases.
[9] J. Mertsola,et al. Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] L. Mofenson,et al. Antimicrobial-specific cell-mediated immune reconstitution in children with advanced human immunodeficiency virus infection receiving highly active antiretroviral therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] N. Day,et al. Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in children with human immunodeficiency virus undergoing highly active antiretroviral therapy. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[12] E. Mallet,et al. Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5-6-year-old children after primary vaccination and first booster with a pentavalent combined acellular pertussis vaccine: immunogenicity and tolerance of a tetravalent combined acel , 2004, Vaccine.
[13] M. Newport,et al. Genetic regulation of immune responses to vaccines in early life , 2004, Genes and Immunity.
[14] J. Cherry,et al. Serologic response and antibody-titer decay in adults with pertussis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] S. Edberg,et al. Identification of Bordetella pertussis in a Critically Ill Human Immunodeficiency Virus-Infected Patient by Direct Genotypical Analysis of Gram-Stained Material and Discrimination from B. holmesii by Using a Unique recA Gene Restriction Enzyme Site , 2004, Journal of Clinical Microbiology.
[16] N. Roberts,et al. Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. , 2003, The Journal of infectious diseases.
[17] K. Crothers,et al. Recurrence of Pneumocystis carinii pneumonia in an HIV‐infected patient: apparent selective immune reconstitution after initiation of antiretroviral therapy , 2003, HIV medicine.
[18] M. Lederman,et al. Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection , 2003, AIDS.
[19] N. Greenspan,et al. Genetic Variation Influences the B-Cell Response to Immunization with a Pneumococcal Polysaccharide Conjugate Vaccine , 2003, Infection and Immunity.
[20] D. Musher,et al. Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccine. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] T. Chun,et al. Deleterious Effect of HIV-1 Plasma Viremia on B Cell Costimulatory Function , 2003, The Journal of Immunology.
[22] K. Mohan,et al. Response to immunization with measles, tetanus, and Haemophilus influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection and are treated with highly active antiretroviral therapy. , 2003, Pediatrics.
[23] D. Wohl,et al. Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. , 2001, The Journal of infectious diseases.
[24] C. Chan,et al. Immunization of HIV-infected children with varicella vaccine. , 2001, The Journal of pediatrics.
[25] J. Englund,et al. Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] J. Ward,et al. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] M. Pichichero,et al. Fifth vaccination with diphtheria, tetanus and acellular pertussis is beneficial in four- to six-year-olds , 2001, The Pediatric infectious disease journal.
[28] P. Nibbering,et al. Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults. , 2000, Vaccine.
[29] P. van Damme,et al. A randomised controlled trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine in adults. , 2000, Vaccine.
[30] R. Schneerson,et al. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. , 2000, The Journal of infectious diseases.
[31] M. de Martino,et al. Pertussis immunization in HIV-1-infected infants: a model to assess the effects of repeated T cell-dependent antigen administrations on HIV-1 progression. Italian Register for HIV infection in children. , 2000, Vaccine.
[32] M. Pichichero,et al. Safety and Immunogenicity of Six Acellular Pertussis Vaccines and One Whole-Cell Pertussis Vaccine Given as a Fifth Dose in Four- to Six-Year-Old Children , 2000, Pediatrics.
[33] P. Nibbering,et al. Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-year follow-up of antibody concentrations. , 1999, Vaccine.
[34] W. Keitel,et al. A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization. , 1999, The Journal of infectious diseases.
[35] J. Gornbein,et al. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. , 1998, Vaccine.
[36] H. Hallander,et al. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. , 1998, Vaccine.
[37] A. Osterhaus,et al. Restored humoral immune response to influenza vaccination in HIV‐infected adults treated with highly active antiretroviral therapy , 1998, AIDS.
[38] E. Grimprel,et al. Comparative reactogenicity and immunogenicity of booster doses of diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine and diphtheria-tetanus-inactivated poliovirus vaccine in preadolescents. , 1998, The Pediatric infectious disease journal.
[39] P. Schneider,et al. The influence of major histocompatibility complex class II genes and T-cell Vbeta repertoire on response to immunization with HBsAg. , 1998, Human immunology.
[40] M. Pichichero,et al. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. , 1997, Pediatrics.
[41] F. Mannelli,et al. Acellular pertussis vaccine in children with perinatal human immunodeficiency virus-type 1 infection. , 1997, Vaccine.
[42] M. Knuf,et al. Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age. , 1997, The Journal of pediatrics.
[43] C. Amos,et al. Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides. , 1997, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[44] D Greco,et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. , 1996, The New England journal of medicine.
[45] M. Pichichero,et al. Comparison of 13 acellular pertussis vaccines: overview and serologic response. , 1995, Pediatrics.
[46] R. Colebunders,et al. Bordetella pertussis as a cause of chronic respiratory infection in an AIDS patient , 1994, European Journal of Clinical Microbiology and Infectious Diseases.
[47] M. Pichichero,et al. Comparison of 13 acellular pertussis vaccines: adverse reactions. , 1993, Pediatrics.
[48] P. Nordmann,et al. Asymptomatic Giardia infection. , 1992 .
[49] B. Doebbeling,et al. Pertussis in an adult man infected with the human immunodeficiency virus. , 1990, The Journal of infectious diseases.
[50] P. Adamson,et al. Pertussis in a previously immunized child with human immunodeficiency virus infection. , 1989, The Journal of pediatrics.
[51] G. Merenstein. University of Colorado School of Medicine. , 2000, Academic medicine : journal of the Association of American Medical Colleges.
[52] P. Nordmann,et al. Whooping cough associated with Bordetella parapertussis in a human immunodeficiency virus-infected child. , 1992, The Pediatric infectious disease journal.
[53] G. Beeson,et al. in adults with , 2019 .